As of Nov 30
| +0.20 / +5.43%|
The 2 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +67.53% increase from the last price of 3.88.
The current consensus among 2 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.